Oral zinc sulphate supplementation for six months in SCA2 patients: A randomized, double-blind, placebo-controlled trial

Article

Abstract: Cuban patients with Spinocerebellar Ataxia type 2 (SCA2) have reduced concentrations of zinc in seru

Palabras claves:

Clinical trial, SCA2, Spinocerebellar ataxia 2, Zn supplementation

Autores:

Aguilera-Rodríguez R., Almaguer Mederos L.E., Batista I.H., Canales-Ochoa N., García-Rodriguez J.C., Gotay D.A., Laffita Mesa J.M., Novas A.J., Orestes Darío López-Hernández, Polanco I.D., Porto-Verdecia M., Pupo N.R., Rodríguez-Chanfrau J.E., Rodríguez-Díaz J.C., Rodríguez-Labrada R., Sánchez-Cruz G., Triana C.G., Velazquez-Perez L.

Fuentes:

google

scopus